News | Cardiac Imaging | March 16, 2017

Siemens Healthineers Highlights Simplicity in Complex Procedures at ACC 2017

Company addresses medical imaging’s rapidly expanding role in the guidance of cardiovascular procedures

Siemens Healthineers, ACC 2017, syngot CTO Guidance, Compressed Sensing Cardiac Cine

March 16, 2017 — During the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC), March 17-19 in Washington, D.C., Siemens Healthineers will showcase technologies that integrate images and information at every step of the treatment process, with a theme of “Making Complex Simple.”

From minimally invasive structural heart procedures to the treatment of highly complex coronary disease, medical imaging is playing an increasingly vital role in guiding and simplifying complex cardiovascular procedures. As imaging’s role intensifies, Siemens Healthineers will highlight recent innovations such as syngo CTO Guidance, a software application that fuses computed tomography with fluoroscopy to aid patients with difficult-to-treat coronary total occlusions. The company said this technology could potentially result in a more successful procedure using reduced levels of radiation and contrast. 

Another new imaging innovation from Siemens Healthineers, Compressed Sensing Cardiac Cine, accelerates the acquisition of magnetic resonance (MR) images by factors of more than 10. This enables clinicians to image the entire left ventricle in just one breath-hold for fast evaluation of wall abnormalities caused by coronary stenosis. Similarly, the company’s CLEARStent Live software enables real-time enhancement of stents as well as cardiac motion compensation during the delicate tasks of positioning and deployment.

For more information: www.usa.healthcare.siemens.com

Related Content

A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes according to a late-breaking study at ACC 2018.
News | ACC | March 20, 2018
March 20, 2018 — The anti-inflammatory...
Dabigatran Reduces Major Cardiovascular Complications in Patients With Myocardial Injury after Noncardiac Surgery
News | ACC | March 20, 2018
March 20, 2018 — Treatment with the blood-thinning drug dabigatran significantly reduced the risk of death, heart att
Statins May Bring Benefits at Time of Treatment for Heart Attack, Angina

Image from presentation, "Statins Evaluation in Coronary Procedures and Revascularization," Berwanger 

News | ACC | March 20, 2018
March 20, 2018 — Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broa
Overlay Init